ABC
- NYSE - Medical-Whlsle Drg/Suppl
Amerisourcebergen Corp
|
$84.93 |
-4.58 -5.11%
|
$90.76
|
$97.50
|
-12.90% |
1,278,207 68.68%
|
1,861,000
|
Most Recent Note for ABC - 3/18/2020 12:38:29 PM
Reported earnings +10% on +5% sales revenues for the Dec '19 quarter. Prior earnings were below the +25% minimum (C criteria). Its annual earnings (A criteria) growth has been slow and steady.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ACIA
- NASDAQ - Telecom-Fiber Optics
Acacia Communications
|
$63.21 |
-1.03 -1.60%
|
$64.00
|
$69.00
|
-8.39% |
401,716 78.61%
|
511,000
|
Most Recent Note for ACIA - 3/18/2020 12:38:42 PM
Undercutting its 200 DMA line. Reported Dec '19 quarterly earnings +17% on +20% sales revenues. Consolidating since 7/09/19 M&A news with Cisco Systems (CSCO). Reported strong Sep and Jun '19 quarterly results after noted in the prior mid-day reports - "Earnings rose +270% on +44% sales revenues for the Mar '19 quarter, its 2nd strong quarterly comparison. Prior 5 quarterly comparisons showed shrinking sales and earnings versus the year ago periods. Went through a deep consolidation since noted with caution after it proposed a new Public Offering on 9/26/16, up from its $23 IPO on 5/13/16,"
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AKAM
- NASDAQ - INTERNET - Internet Software & Services
Akamai Technologies Inc
|
$90.59 |
+2.16
2.44%
|
$91.58
|
$103.34
|
-12.34% |
1,224,046 75.19%
|
1,628,000
|
Most Recent Note for AKAM - 3/18/2020 12:40:14 PM
Slumped from multi-year highs and it is rebounding near its 50 DMA line today. Prior mid-day reports cautioned members - "Reported earnings +15% on +8% sales revenues for the Dec '19 quarter, below the +25% minimum earnings guideline (C criteria). Sub par sales revenues growth remains a concern. Went through a choppy consolidation since dropped from the Featured Stocks list on 6/15/15."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AMN
- NYSE - Comml Svcs-Staffing
A M N Healthcare Svcs
|
$78.68 |
-1.60 -1.99%
|
$81.48
|
$80.55
|
-2.32% |
465,090 111.80%
|
416,000
|
Most Recent Note for AMN - 3/18/2020 12:41:23 PM
Reversed into the red after reaching a new 52-week high today. Tallied big volume-driven gains after testing its 200 DMA line last week. Quarterly sales and earnings history through Dec '19 has not been a match with the fundamental guidelines of the fact-based investment system. Annual earnings (A criteria) growth had a downturn on FY '19.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BJ
- NYSE - Retail-Discount&Variety
BJs Wholesale Club Hldgs
|
$28.93 |
+1.94
7.19%
|
$29.41
|
$29.41
|
-1.63% |
1,724,683 84.58%
|
2,039,000
|
Most Recent Note for BJ - 3/18/2020 12:43:03 PM
Challenging its 52-week high today. Rebounded impressively with big volume-driven gains in the past 3 weeks. Fundamental concerns remain. Went through a deep consolidation after noted with caution in the 11/20/19 mid-day report - "Unimpressive sales growth and quarterly earnings history (C criteria). Completed its new IPO at $17 on 6/28/19."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CVBF
- NASDAQ - BANKING - Regional - Pacific Banks
C V B Financial Corp
|
$19.15 |
-0.30 -1.54%
|
$19.59
|
$22.26
|
-13.97% |
726,082 111.02%
|
654,000
|
Most Recent Note for CVBF - 3/18/2020 12:44:37 PM
Quarterly and annual earnings history (C and A criteria) has not been a match with the fundamental guidelines of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DG
- NYSE - RETAIL - Discount, Variety Stores
Dollar General Corp
|
$150.67 |
-3.86 -2.50%
|
$157.65
|
$167.44
|
-10.02% |
1,790,148 80.93%
|
2,212,000
|
Most Recent Note for DG - 3/18/2020 12:45:18 PM
Sputtering near its 200 DMA line ($151) after an abrupt slump from its all-time high. Reported earnings +12% on +8% sales revenues for the Jan '20 quarter and prior quarters were below the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth history has been steady.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
EBS
- NYSE - DRUGS - Biotechnology
Emergent Biosolutions
|
$61.18 |
+3.53
6.11%
|
$63.51
|
$71.19
|
-14.07% |
375,642 86.35%
|
435,000
|
Most Recent Note for EBS - 3/18/2020 12:45:54 PM
Recent gains challenged its all-time high. Reported earnings +101% on +33% sales revenues for the Dec '19 quarter, its 2nd strong quarterly comparison versus the year ago period. Fundamental concerns remain. Noted in prior mid-day reports - "Prior quarterly and annual earnings history (C and A criteria) is not a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HE
- NYSE - UTILITIES - Electric Utilities
Hawaiian Electric Inds
|
$50.12 |
+0.81
1.64%
|
$50.90
|
$52.96
|
-5.36% |
507,087 81.92%
|
619,000
|
Most Recent Note for HE - 3/18/2020 12:47:12 PM
Perched at its all-time high with today's 4th consecutive volume-driven gain. Concerns remain as when noted with caution in the 8/13/10 mid-day report - "Erratic quarterly earnings and sales history and up and down annual earnings (the A criteria) history raise fundamental concerns."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MLNX
- NASDAQ - ELECTRONICS - Semiconductor - Broad Line
Mellanox Technologies
|
$106.44 |
-3.65 -3.32%
|
$109.36
|
$123.79
|
-14.02% |
573,770 70.75%
|
811,000
|
Most Recent Note for MLNX - 3/18/2020 12:51:11 PM
Previously noted M&A news with Nvidia (NVDA). Slumped well below its 200 DMA line ($113). This Israel-based Electronics - Semiconductor firm reported earnings +63% with sales revenues +31% for the Dec '19 quarter versus the year ago period. Three of the past 4 comparisons were above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history included a downturn in FY '17, not a good match with the fact-based investment system's guidelines. It was dropped from the Featured Stocks list on 7/17/12.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PG
- NYSE - CONSUMER NON-DURABLES - Cleaning Products
Procter & Gamble
|
$119.01 |
+0.77
0.65%
|
$121.50
|
$128.09
|
-7.09% |
6,932,279 75.75%
|
9,152,000
|
Most Recent Note for PG - 3/18/2020 12:51:47 PM
Sputtering below its 200 DMA line and recent sessions have been marked by wider than usual intra-day price swings indicative of great uncertainty. Earnings history is not a match with the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
REGN
- NASDAQ - DRUGS - Biotechnology
Regeneron Pharmaceutical
|
$484.08 |
-7.61 -1.55%
|
$499.00
|
$512.98
|
-5.63% |
1,088,230 90.01%
|
1,209,000
|
Most Recent Note for REGN - 3/18/2020 12:53:42 PM
Perched at its 52-week high. Held its ground stubbornly following volume-driven gains. Prior mid-day reports noted - "Reported earnings +10% on +13% sales revenues for the Dec '19 quarter, and prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Downturn in FY '15 earnings was a noted flaw in its annual earnings (A criteria) history."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
RGEN
- NASDAQ - Medical - Products
Repligen Corp
|
$95.77 |
-1.80 -1.84%
|
$100.99
|
$109.94
|
-12.89% |
332,859 67.65%
|
492,000
|
Most Recent Note for RGEN - 3/18/2020 12:54:13 PM
Consolidating between support at its 200 DMA line and resistance at its 50 DMA line after abruptly retreating from its all-time high. Gapped down from its high when last noted with caution in the 2/20/20 mid-day report - "Completed Public Offerings on 7/17/19 and 5/01/19. Reported Dec '19 earnings +5% on +34% sales revenues, and fundamental concerns remain. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
RMD
- NYSE - HEALTH SERVICES - Medical Appliances & Equipment
Resmed Inc
|
$156.00 |
-5.43 -3.36%
|
$158.81
|
$177.99
|
-12.35% |
660,364 99.30%
|
665,000
|
Most Recent Note for RMD - 3/18/2020 12:55:53 PM
Retreated from its all-time high and found support near its 200 DMA line. Reported earnings +21 on +13% sales revenues for the Dec '19 quarter, its 5th comparison below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) growth after a downturn in FY '15 has been slow and steady, not a great match with the winning models of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TR
- NYSE - FOOD & BEVERAGE - Confectioners
Tootsie Roll Industries
|
$35.82 |
+0.33
0.93%
|
$36.45
|
$39.63
|
-9.61% |
89,450 65.77%
|
136,000
|
Most Recent Note for TR - 3/18/2020 12:56:51 PM
Rebounded above its 200 DMA line on the prior session with a big gain after a long and deep consolidation. Concerns remain as when noted with caution in the 6/30/16 mid-day report with caution - "Fundamentals fall short of the C and A criteria of the fact-based investment system and its lack of sales revenues growth indicates no demand for any new (N criteria) products."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
WABC
- NASDAQ - BANKING - Regional - Pacific Banks
Westamerica Bancorp
|
$61.84 |
+1.41
2.33%
|
$62.30
|
$69.08
|
-10.48% |
93,655 91.82%
|
102,000
|
Most Recent Note for WABC - 3/18/2020 12:58:19 PM
Quarterly earnings increases through Dec '19 have been below the +25% minimum guideline (C criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ZM
- NASDAQ - Computer Sftwr-Enterprse
Zoom Video Comm Cl A
|
$115.40 |
+4.30
3.87%
|
$117.76
|
$129.83
|
-11.11% |
6,763,352 91.79%
|
7,368,000
|
Most Recent Note for ZM - 3/18/2020 1:00:19 PM
Still stubbornly holding its ground perched near its all-time high. Completed its $36.00 IPO on 4/18/19. Limited annual history (A criteria) is a concern. Reported earnings +275% on +78% sales revenues for the Jan '20 quarter. Prior quarterly comparisons also showed very strong sales revenues and great earnings increases versus the year ago periods.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|